HOXB9 expression significantly decreased in adenocarcinomas with a tumor size larger than 5 cm or with lymph node metastasis or at a late TNM stages (stage III or IV). This evidence concerns the gene HOXB9 and metastatic malignant neoplasm in the lymph nodes.